Beta Drugs Limited (NSE:BETA)

Beta Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 22, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	15,171	19,235	11,861	6,027	5,437	1,038
Market Cap Growth	-21.03%	62.17%	96.79%	10.87%	423.79%	200.00%
Enterprise Value	15,403	19,147	11,782	6,023	5,446	1,127
Last Close Price	1502.90	1905.50	1175.00	597.10	538.57	114.29
PE Ratio	28.02	45.35	32.55	19.62	21.90	8.85
PS Ratio	3.93	5.31	4.01	2.65	2.96	0.89
PB Ratio	6.86	9.76	7.55	4.91	5.89	1.51
P/TBV Ratio	7.16	10.20	7.82	5.10	6.17	1.59
P/FCF Ratio	-	-	61.41	116.57	53.30	8.08
P/OCF Ratio	60.22	53.22	38.35	25.78	18.35	5.58
EV/Sales Ratio	3.99	5.28	3.98	2.65	2.96	0.97
EV/EBITDA Ratio	20.35	26.06	19.67	11.27	12.75	4.55
EV/EBIT Ratio	24.83	30.84	23.50	14.00	15.37	6.29
EV/FCF Ratio	-43.84	-	61.00	116.49	53.39	8.77
Debt / Equity Ratio	0.66	0.70	0.09	0.17	0.22	0.26
Debt / EBITDA Ratio	1.93	1.88	0.25	0.38	0.48	0.70
Debt / FCF Ratio	-	-	0.76	3.93	2.02	1.36
Asset Turnover	0.99	1.05	1.31	1.27	1.34	1.03
Inventory Turnover	3.65	3.88	4.51	4.88	5.83	5.09
Quick Ratio	2.12	2.54	1.42	1.43	1.42	1.45
Current Ratio	3.09	3.22	2.10	2.03	1.98	2.04
Return on Equity (ROE)	20.85%	23.95%	26.03%	28.54%	30.85%	18.65%
Return on Assets (ROA)	9.91%	11.24%	13.85%	15.10%	16.09%	9.97%
Return on Invested Capital (ROIC)	18.91%	27.91%	28.04%	29.31%	29.96%	17.56%
Return on Capital Employed (ROCE)	16.60%	18.60%	29.60%	31.80%	32.60%	21.30%
Earnings Yield	2.76%	2.21%	3.07%	5.10%	4.57%	11.30%
FCF Yield	-2.32%	-0.04%	1.63%	0.86%	1.88%	12.38%
Buyback Yield / Dilution	22.61%	-5.00%	4.76%	-	-	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.